The critical link between clinical risk stratification and pharmacovigilance in tuberculosis therapy: implications for rifampicin-induced cholestatic jaundice

Journal of Clinical Tuberculosis and Other Mycobacterial Diseases · Published 2026-05-01 · DOI 10.1016/j.jctube.2026.100614

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.1016/j.jctube.2026.100614

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Related articles